Introduction
============

To compare the incidence of ventilator-associated pneumonia (VAP) using an endotracheal tube with a polyurethane cuff, designed to reduce channel formation, and subglottic secretion drainage (ETT-PUC-SSD) versus an conventional endotracheal tube (ETT-C) with a polyvinyl cuff and without subglottic secretion drainage.

Methods
=======

A clinical randomized trial, between 1 March 2006 and 31 October 2006 in a medical--surgical ICU. Were included patients requiring mechanical ventilation during more than 24 hours. Patients were randomized into two groups: one group was ventilated with ETT-PUC-SSD and another group with ETT-C. Throat swabs and tracheal aspirates were taken at the moment of admission and twice a week until discharge. The infections were classified based on thorat flora as: primary endogenous, caused by germs that were already colonizing the throat on the ICU admission; secondary endogenous, caused by germs that were not colonizing the throat on the ICU admission but were acquired during the stay in ICU; and exogenous, caused by germs that were not colonizing the throat.

Results
=======

There were no significant differences between both groups of patients in age, sex, diagnosis groups, APACHE II score, pre-VAP use of antibiotics, paralytic agents, reintubation, tracheostomy, and days on mechanical ventilation. VAP was found in 31 of 140 (22.1%) patients in the ETT-C group and in 11 of 140 (7.9%) in the ETT-PUC-SSD group (*P*= 0.001). Cox regression analysis showed CET as a risk factor for global VAP (hazard rate = 3.3, 95% CI = 1.66--6.67, *P*= 0.001), primary endogenous VAP (hazard rate = 5.12, 95% CI = 1.12--23.38, *P*= 0.04) and secondary endogenous VAP (hazard rate = 2.87, 95% CI = 1.20--6.84, *P*= 0.02); but not for exogenous VAP.

Conclusion
==========

The endotracheal tube with a polyurethane cuff and subglottic secretion drainage is effective to prevent primary endogenous and secondary endogenous VAP.
